Anti Wrinkle treatments at S3 Dental and S3 Facial Aesthetics involve the use of botulinium toxin type A.

Botox®, Dysport or Azzalure are approved product names for the for the botulinium toxin and are incredibly popular treatments for the cosmetic treatments of wrinkles and frown lines.

Both products work in a similar fashion, where they inhibit stimulation of nerves. This causes the muscles that cause facial wrinkles to relax. The more relaxed the muscles are the less strength they have to produce folds in the skin. It is the contraction of the facial muscles that overtime cause these folds to occur and become deeper and permanent.

Research between products shows that depending on the area to be treated, that one product may be more effective than the other. Our expertly trained team will advise you on the best product to get you the best looking result.

Treatments with botulinium toxin type A - Botox, Dysport or Azzalure are not only confined to cosmetic treatments. They can be used for the variet of treatments such as migraines, TMJ problems or excessive sweating - Hyperhidrosis.

Botox treatments are determined by the area and case dependent, and we offer treatments subject to a consultation.

Most patients are suitable for Botox related treatments but in certain circumstances we may not be able to provide treatment.

Patients who are pregnant or breastfeeding, certain allergies such as to egg protein or with an infection in the area. All patients will be assessed prior to treatment and required to fill in a medical history form on their consultation and are responsible for updating us if their medical history changes.

If you have suffered from side effects after previous Botox treatments then it is important to inform us. Botox treatments provided at S3 Facial Aesthetics are administered in safe dosages and by clinically trained surgeons.

Rare side effects are headaches, eyelin ptosis (drooping), blurred vision, dizziness and dry mouth. Contact one of our clinical surgeons if you would like to know more.